In the ISAAC trial, household contacts of iGAS (Invasive Group A Strep) cases will be invited to participate in the study. People who take part will be randomised to receive …
CONDITION: Infection
GENDER: All
AGE GROUP:?0?and above
TRIAL STATUS:?Recruiting
Novatrials is seeking volunteers who are overweight and living with type 2 diabetes for a clinical study of a potential new treatment. The study medication is a once-weekly injection just …
CONDITION: Other
GENDER: Both males and females
AGE GROUP:?18?and above
TRIAL STATUS:?Recruiting
Novatrials is seeking healthy volunteers to join a clinical study of a new potential treatment for kidney dysfunction. As part of this trial, you may receive the study drug or …
CONDITION: Other
GENDER: Both males and females
AGE GROUP:?18?to 65 years
TRIAL STATUS:?Recruiting
Healthy Volunteer Weight Loss Study | 3-Night In-Clinic Stay Novatrials is seeking healthy volunteers to join a clinical study of a potential new weight loss treatment. The purpose of this …
CONDITION: Other
GENDER: Both males and females
AGE GROUP:?18?to 60 years
TRIAL STATUS:?Recruiting
If you, or someone you know, are suffering from diagnosed PTSD, Novatrials is looking for volunteers to participate in a potential new treatment study. About the Study The study aims …
CONDITION: Mental Health
GENDER: Both males and females
AGE GROUP:?18?to 65 years
TRIAL STATUS:?Recruiting
Australian researchers are looking for healthy volunteers to test a potential new medical treatment for Idiopathic Pulmonary Fibrosis (IPF). IPF is a lung condition that causes progressive scarring of the …
CONDITION: Respiratory
GENDER: Both males and females
AGE GROUP:?26?to 65 years
TRIAL STATUS:?Recruiting
Subcutaneous abdominal fat is the soft, pinchable layer located directly under the skin. High levels may be linked to health concerns like high blood pressure, elevated cholesterol, and elevated blood …
CONDITION: Other
GENDER: Both males and females
AGE GROUP:?18?and above
TRIAL STATUS:?Recruiting
Novatrials is recruiting volunteers who are living with obesity for a clinical study of a potential new treatment. The study medication is a once-weekly injection into the skin. It is …
CONDITION: Diet and Nutrition
GENDER: Both males and females
AGE GROUP:?18?and above
TRIAL STATUS:?Recruiting
This is a Phase IIa, randomized, double-blind, placebo-controlled pilot study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of ONP-002 in adults with mild traumatic brain injury (mTBI). …
CONDITION: Injuries and Accidents
GENDER: All
AGE GROUP:?18?to 75 years
TRIAL STATUS:?Recruiting
Immune-mediated diseases are a broad category of conditions where the immune system functions abnormally and the immune response is inappropriate or excessive, resulting in harm to the body. Autoimmune diseases …
CONDITION: Inflammatory and Immune System
GENDER: Both males and females
AGE GROUP:?18?to 75 years
TRIAL STATUS:?Recruiting
Do you have high cholesterol and high triglycerides? This common condition, called mixed hyperlipidaemia, means your blood contains too much of certain fats. When left untreated, it can increase your …
CONDITION: Cardiovascular
GENDER: Both males and females
AGE GROUP:?18?and above
TRIAL STATUS:?Recruiting
Novatrials is seeking volunteers with non-melanoma skin cancer to participate in a clinical study of a potential new treatment using a non-invasive device that emits a very gentle whole-body pulsed …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP:?40?to 75 years
TRIAL STATUS:?Recruiting
About the Study This study is assessing whether a new targeted therapy (olomorasib) in combination with standard of care anti-cancer drugs (including immunotherapy and chemotherapy) is more effective than just …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP:?18?and above
TRIAL STATUS:?Recruiting
About the Study The main purpose of this study is to test a potential new treatment for early breast cancer. The study will measure how well a new hormone therapy …
CONDITION: Cancer
GENDER: All
AGE GROUP:?18?and above
TRIAL STATUS:?Recruiting
The purpose of this study is to determine if BHV-1300 is a safe treatment in participants with Graves’ Disease and to explore its effect on disease-specific biomarkers.
CONDITION: Metabolic and Endocrine
GENDER: Both males and females
AGE GROUP:?18?to 65 years
TRIAL STATUS:?Recruiting
Novatrials is enrolling volunteers with cardiovascular disease, and are living with obesity, in a clinical study of a potential new treatment that may help improve heart health outcomes. You may …
CONDITION: Cardiovascular
GENDER: Both males and females
AGE GROUP:?45?to 85 years
TRIAL STATUS:?Recruiting
In Australia, 2,000 people a day are treated for skin cancer and 2 in 3 Australians will be diagnosed with skin cancer by the age of 70. Your participation supports research designed …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP:?18?to 85 years
TRIAL STATUS:?Recruiting
REZOLV3R is a randomised, double-blind, multi-centre trial treating symptomatic patients with recurrent malignant ascites suitable for paracentesis and a paracentesis-free interval of 28 days or less. The aim of the …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP:?18?and above
TRIAL STATUS:?Recruiting
Australian researchers are testing a potential new treatment for obesity and weight-related comorbidities in adolescents. This is a 76 week study and may include up to 23 visits. Your adolescent …
CONDITION: Diet and Nutrition
GENDER: All
AGE GROUP:?12?to 17 years
TRIAL STATUS:?Recruiting
The objective of ASPIRE-AF is to assess the feasibility of a randomized controlled trial of non-vitamin K oral anticoagulants versus usual care in patients with perioperative atrial fibrillation (AF) after …
CONDITION: Cardiovascular
GENDER: Both males and females
AGE GROUP:?55?and above
TRIAL STATUS:?Recruiting
Australian researchers are testing a potential new treatment for atopic dermatitis (eczema) in children. This is a 36 week study with at least 12 separate visits. Your child will be …
CONDITION: Skin
GENDER: All
AGE GROUP:?6?to 17 years
TRIAL STATUS:?Recruiting
Aims: to document the efficacy and safety outcomes of SCS in persons with chronic, chemotherapy-induced peripheral neuropathy Types of chemotherapy: Taxotere, Oxaliplatin, Paclitaxel Primary outcome measure: % responder rate at …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP:?18?to 100 years
TRIAL STATUS:?Recruiting